Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mitsubishi reports isolation of PI 3-kinase inhibitors

Sep. 27, 1996

Prostate cancer treatment approved by the FDA

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Joint venture to develop Biopharmaceutics' orphan anticancer drug

Sep. 27, 1996

First patent for IL-15

Sep. 20, 1996

Pharmacyclics signs manufacturing and supply agreement for texaphyrin products

Sep. 20, 1996

Potential DNA vaccine for B-cell lymphoma

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

New cancer therapy from The Liposome Company advances to full development

Sep. 20, 1996

Novel anticancer tyrosine kinase inhibitors from Pharmacia & Upjohn

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 8, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...